European Heart Journal
Oxford University Press · Clinical Medicine · ISSN 0195-668X, 1522-9645
- Impact (2-yr)
- 2.9
- h-index
- 463
- Open access
- 31%
- Works
- 74.9K
- Papers this month
- 154
Rebuilt
Latest in EHJ
Newest first · last 60 days
AI summary · may contain errors
Higher white blood cell count is strongly associated with greater 6-year subclinical atherosclerosis plaque burden in 3,471 middle-aged asymptomatic participants, increasing global plaque volume by 32.6% per 1 SD.
AI summary · may contain errors
A 48 g/day increment in whole-grain intake in randomized trials is linked to lower body weight by a mean difference of -0.20 kg (95% CI -0.31 to -0.09; n=41).
AI summary · may contain errors
A structured collaboration framework for academia–medical industry partnerships defines six integrity principles—transparency, independence, accountability, equity, sustainability, and patient-centred benefit—to strengthen governance.
AI summary · may contain errors
In 508 hypertrophic cardiomyopathy patients with prior negative NGS testing, retesting with an updated panel found HCM-related variants in 9% (46/508), including new and reclassified findings.
AI summary · may contain errors
Sacubitril/valsartan prophylaxis is linked to improved left ventricular global longitudinal strain and aortic compliance in paediatric post-radiotherapy patients, with a favourable safety profile.
AI summary · may contain errors
In the FINE-HEART pooled analysis of 18 991 advanced cardiovascular-kidney-metabolic participants, women had higher multimorbidity and lower all-cause mortality risk (adjusted HR 0.83).
AI summary · may contain errors
The Acute Aortic Syndrome Rule-Out Criteria (ARC) identifies low-risk suspected acute aortic syndrome patients with 100% sensitivity in external cohorts, enabling safe rule-out without missing cases.
AI summary · may contain errors
Prophylactic SynFlow 3.0 micro-axial flow pump during non-emergent high-risk PCI in patients with LVEF ≤35% is non-inferior to VA-ECMO for 30-day major adverse events (7.34% vs 11.5%).
AI summary · may contain errors
Beta-blocker trial participants in BETAMI-DANBLOCK had lower 3-year absolute risk of all-cause mortality or MI (7.7%–7.8%) than Norway’s NORMI revascularized MI cohort (12.0%).
AI summary · may contain errors
In CRT candidates with typical left bundle branch block, left-bundle branch area pacing did not meet non-inferiority versus biventricular pacing for 6-month positive response (89.7% vs 94.6%).
AI summary · may contain errors
In 2057 post-hospitalization acute coronary syndrome patients, a nurse-coordinated prevention program reduced long-term MACE versus standard care (16.2% vs 22.6%; HR 0.70).
Browse JClub
Journals this month
- bioRxiv6366
- medRxiv1720
- PNAS508
- Sci Adv379
- JAMA333
- Cell Rep302
- Environ Pollution234
- Environ Res217
- BMJ214
- Nat Commun190
- Science185
- NEJM170
- Plant Cell Environ169
- New Phytol157
- NAR157
- EHJ154
- Lancet151
- Curr Biol129
Topics moving, week to 13 Nov 2026
- Single-cell and spatial transcriptomics8
- CAR-T cell therapy research7
- CRISPR and Genetic Engineering6
- Lung Cancer Treatments and Mutations4
- Pancreatic and Hepatic Oncology Research4
- Gut microbiota and health4
- Lipoproteins and Cardiovascular Health3
- Genomics and Phylogenetic Studies3
- Inflammatory Bowel Disease3
- RNA and protein synthesis mechanisms3
